Overall, these findings suggest that dysregulation of the miR-124/IL-11 axis affects tumor-stromal interactions during the bone metastasis of breast cancer, thus exerting a negative influence on clinicopathological characteristics and the survival of breast cancer patients with bone metastasis (Fig. 7i). This evidence concerns the gene IL11 and breast carcinoma.